The Role of Non-Selective β-Blockers in Compensated Cirrhotic Patients without Major Complications
<i>Background and Objectives</i>: Non-selective β-blockers (NSBB) could prevent decompensation and hepatocellular carcinoma (HCC) in cirrhotic patients with clinically significant portal hypertension (CSPH), but remained uncertain for compensated cirrhotic patients without major...
Main Authors: | Wen-Shuo Yeh, Shih-Cheng Yang, Chih-Ming Liang, Yu-Chi Li, Wei-Chen Tai, Chen-Hsiang Lee, Yao-Hsu Yang, Chien-Ning Hsu, Tzu-Hsien Tsai, Seng-Kee Chuah, Cheng-Kun Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-12-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1010-660X/56/1/14 |
Similar Items
-
What’s New in Cirrhotic Cardiomyopathy?—Review Article
by: Aleksandra Bodys-Pełka, et al.
Published: (2021-12-01) -
Minocycline attenuates cirrhotic cardiomyopathy and portal hypertension in a rat model: Possible involvement of nitric oxide pathway
by: Seyyedeh Elaheh Mousavi, et al.
Published: (2016-11-01) -
A Narrative Review on Non-Cirrohotic Portal Hypertension: Not All Portal Hypertensions Mean Cirrhosis
by: Michele Fiordaliso, et al.
Published: (2023-10-01) -
Natural History of Hepatosplenic Schistosomiasis (HSS) Non–Cirrhotic Portal Hypertension (NCPH): Influence of Gastrointestinal Bleeding and Decompensation in Prognosis
by: Zulane S. T. Veiga, et al.
Published: (2023-02-01) -
Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction
by: Florent Artru, et al.
Published: (2022-08-01)